The supply of GLP-1 drugs has been increasing, but they’re still expensive for most patients. Here are answers to some ...

By Dennis Thompson HealthDay ReporterWEDNESDAY, May 28, 2025 (HealthDay News) — Popular GLP-1 weight loss drugs like Ozempic ...

Losing just 6.5% of body weight in midlife may lower later risk of disease and premature death, new research shows.

We are just starting to learn more about the systemic impact of these medications,” Dr. Shiara Ortiz-Pujols told The Post.

A recent study reveals that weight-loss medications such as Ozempic may reduce the risk of obesity-related cancers, including ...

Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand access soon.

Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...

Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...

GLP-1 receptor agonists may modestly reduce the risk for 14 obesity-related cancers, especially colorectal cancer, among ...

There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...

Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when ...

and better studies to determine whether this is related to the medication itself or just weight loss." "It’s important for all doctors who prescribe these drugs to be aware and check the patient ...